NFKB1 and hepatocellular carcinoma: Liu et al. also demonstrated that in hepatocellular carcinoma, LINC00886 activates the NF-κB pathway and upregulates RAB10 and E2F2 by decreasing the levels of miR-409-3p and miR-214-5p, thereby enhancing the malignant behavior of these cells [29].